Skip to search formSkip to main contentSkip to account menu

Minocycline

Known as: (4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, Minocyclin, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))- 
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Early reperfusion after an ischemic stroke can cause blood–brain barrier injury with subsequent cerebral edema and devastating… 
Highly Cited
2004
Highly Cited
2004
Individuals with Down's syndrome develop Alzheimer's‐like pathologies comparatively early in life, including progressive… 
Highly Cited
2004
Highly Cited
2004
ObjectiveTo determine the efficacy of minocycline and rifampin-impregnated catheters compared to non-impregnated catheters in… 
Highly Cited
2004
Highly Cited
2004
Widely used tetracycline antibiotics affect many cellular functions relevant to human vascular disease including cell… 
Highly Cited
1982
Highly Cited
1982
Two patients receiving minocycline developed blue‐black pigmentation on the legs. Biopsies from the pigmented areas demonstrated…